ZLAB
Zai Lab Limited
Company Overview
| Mkt Cap | $2.79B | Price | $26.13 |
| Volume | 625.92K | Change | +2.39% |
| P/E Ratio | -10.9 | Open | $25.69 |
| Revenue | $397.6M | Prev Close | $25.52 |
| Net Income | $-257.1M | 52W Range | $23.82 - $44.34 |
| Div Yield | N/A | Target | $56.00 |
| Overall | 36 | Value | -- |
| Quality | -- | Technical | 36 |
No chart data available
Stock Overview
Updated DailyZai Lab Limited (ZLAB) is a leading Healthcare company in the Biotechnology industry, currently trading at $26.13 with a market capitalization of $2.79 billion. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows ZLAB with a volume of 626K shares. The stock opened up 0.65% from yesterday's close of $25.52. Current analyst estimates project earnings of $-1.24 per share for this year, with next year targeting $-0.01.
ZLAB demonstrates concerning technical signals based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including OCUP, NXEN, NVS, ODTC.
Key investment considerations for ZLAB include concerning overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 114.3%. The stock shows neutral valuation metrics based on valuation analysis.
Analysis generated on November 2, 2025 at 02:46 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ZLAB | $26.13 | +2.4% | 625.92K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |